Empowering the tissue engineered product field

Cell & Gene Therapy Insights 2024; 10(1), 75–81

DOI: 10.18609/cgti.2024.014

Published: 16 February
Michael Lehmicke, Natalie Fekete

David McCall, Senior Editor, Cell & Gene Therapy Insights, speaks to the Alliance for Regenerative Medicine’s Michael Lehmicke, Senior Vice President, Science and Industry Affairs, and Natalie Fekete, Manager, Science and Industry Affairs, about the aims and outcomes of the Alliance for Regenerative Medicine’s recent Tissue Engineering and Therapeutics Workshop. In light of recently renewed interest in the space, could tissue engineered products be on the verge of fulfilling their long-held potential?